France lists more innovative/costly device to be paid from separate budgets:
This article was originally published in Clinica
Two decrees have been published in the French Journal officiel in November determining medical devices that will be paid for in France over and above the standard stay group tariffs (GHS - a single tariff payment by the government to cover the costs of an entire medical procedure). Products that will be paid for separately, as listed in the decrees published on November 22 and November 1, are certain types of the following: urogenital implants; heart valves; defibrillators; vascular implants; and pacemakers. Industry had lobbied successfully for some of the more costly or innovative products to be paid for separately from the GHS, as it feared that hospitals would otherwise be unable to meet the costs of such products from already-squeezed diagnosis-related group style budgets.